Patents by Inventor Lixin DAI
Lixin DAI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20250011392Abstract: The present disclosure relates to a recombinant collagen, peptide fragments thereof, and sequence variants thereof. A novel Pichia pastoris strain for producing the recombinant collagen, fragments thereof, and sequence variants thereof, and methods of using the recombinant collagen, fragments, and sequence variants thereof are also provided. The present disclosure fulfills a need for environmentally friendly and safe alternatives for skincare.Type: ApplicationFiled: April 29, 2022Publication date: January 9, 2025Inventors: Lixin DAI, Dale L HANDLIN, Jr., Stanley LUE, Monique DE LEEUW, Dan DUEPPEN, Dave WILLIAMSON, Isabelle HANSENNE-CERVANTES, Brenna RAUW
-
Publication number: 20240099955Abstract: The present disclosure relates to a recombinant collagen fragment having a molecular weight of about 55 kDa, and compositions comprising the recombinant collagen fragment. Methods of producing the recombinant collagen fragment and methods of treatment using the recombinant collagen fragment are also provided.Type: ApplicationFiled: February 4, 2022Publication date: March 28, 2024Inventors: Yelena ZOLOTARSKY, Lixin DAI, Dan DUEPPEN
-
Publication number: 20230174955Abstract: The disclosure herein provides a monomeric prolyl 4-hydroxylase. A microorganism including a monomeric prolyl 4-hydroxylase is provided. The disclosure provides a microorganism including a monomeric prolyl 4-hydroxylase; and another protein to be hydroxylated. A method for providing skincare benefits including applying the fusion protein of the present disclosure on skin is also taught.Type: ApplicationFiled: February 12, 2021Publication date: June 8, 2023Applicant: Modern Meadow, Inc.Inventors: Lixin DAI, Poonam SRIVASTAVA, Sumreet Singh JOHAR, Shashwat Mohan VAJPEYI, Mahadevan LAKSHMINARASIMHAN, James Egan WELCH
-
Publication number: 20230033725Abstract: Protein polyurethane alloys including one or more proteins dissolved within one or more polyurethanes. The protein polyurethane alloy may have one or more mechanical properties that are superior to the polyurethane in the absence of protein. The protein polyurethane alloys may be incorporated into a layered material including one or more protein polyurethane alloy layers.Type: ApplicationFiled: August 12, 2022Publication date: February 2, 2023Inventors: Samuel BROADBENT, Dale L. HANDLIN, JR., Shaobo CAI, Zhe TAN, Casey CROWNHART, Nicholas YARAGHI, David WILLIAMSON, Alexander Iain NORMAN, Lixin DAI
-
Patent number: 11530304Abstract: A biofabricated material comprising a network of crosslinked collagen fibrils produced from recombinant collagen that contains substantially no 3-hydroxyproline residues is disclosed. This material is composed of collagen which is also a major component of natural leather and is produced by a process of fibrillation of collagen molecules into fibrils, crosslinking the fibrils and lubricating the crosslinked fibrils. Unlike natural leathers, this biofabricated material exhibits non-anisotropic (not directionally dependent) physical properties, for example, a sheet of biofabricated material can have substantially the same elasticity or tensile strength when stretched or stressed in different directions. Unlike natural leather, it has a uniform texture that facilitates uniform uptake of dyes and coatings. Aesthetically, it produces a uniform and consistent grain for ease of manufacturability.Type: GrantFiled: February 15, 2017Date of Patent: December 20, 2022Assignee: MODERN MEADOW, INC.Inventors: Brendan Patrick Purcell, David Thomas Williamson, Lixin Dai, Darryl Miles Cassingham, Stephen M. Spinella, Katherine Amy Congdon
-
Patent number: 11384135Abstract: This invention relates to genetically engineered strains of yeast and methods, for producing recombinant protein (e.g., collagen). Recombinant protein of the present invention is used to produce biofabricated leather or a material having leather-like properties containing recombinant or engineered collagen. The yeast strains are engineered to produce ascorbate and/or increased production of ? ketoglutarate.Type: GrantFiled: September 7, 2018Date of Patent: July 12, 2022Assignee: MODERN MEADOW, INC.Inventors: Lixin Dai, Poonam Srivastava
-
Patent number: 11312968Abstract: Strains of yeast genetically engineered to produce increased amounts of non-hydroxylated collagen or hydroxylated collagen are described. An all-in-one vector including the DNA necessary to produce collagen, promotors, and hydroxylating enzymes is also described. Methods for producing non-hydroxylated or hydroxylated collagen are also provided.Type: GrantFiled: June 29, 2018Date of Patent: April 26, 2022Assignee: MODERN MEADOW, INC.Inventors: Lixin Dai, Julia Borden, Jeffrey Nelson, Kristin Ruebling-Jass
-
Patent number: 11214844Abstract: The invention herein provides biofabricated materials having zonal properties and methods of making biofabricated materials having zonal properties.Type: GrantFiled: November 13, 2018Date of Patent: January 4, 2022Assignee: Modern Meadow, Inc.Inventors: Brendan Patrick Purcell, Suzanne Lee, Lixin Dai, Katherine Amy Congdon, Stephen M. Spinella, Chi Man Ng
-
Publication number: 20210355326Abstract: Protein polyurethane alloys including one or more proteins dissolved within one or more polyurethanes. The protein polyurethane alloy may have one or more mechanical properties that are superior to the polyurethane in the absence of protein. The protein polyurethane alloys may be incorporated into a layered material including one or more protein polyurethane alloy layers.Type: ApplicationFiled: April 30, 2021Publication date: November 18, 2021Inventors: Samuel BROADBENT, Dale L. HANDLIN, JR., Shaobo CAI, Zhe TAN, Casey CROWNHART, Nicholas YARAGHI, David WILLIAMSON, Alexander Iain NORMAN, Lixin Dai
-
Publication number: 20210308031Abstract: The disclosure herein provides a fusion protein comprising prolyl 4-hydroxylase alpha subunit (P4HA) and a soluble protein partner. A fusion protein comprising prolyl 4-hydroxylase alpha subunit (P4HA1) and prolyl 4-hydroxylase beta subunit (P4HB) is provided. A microorganism including a fusion protein comprising prolyl 4-hydroxylase alpha subunit-1 (P4HA1) and prolyl 4-hydroxylase beta subunit (P4HB) is provided. The disclosure provides a microorganism including a fusion protein comprising prolyl 4-hydroxylase alpha subunit-1 (P4HA1) and prolyl 4-hydroxylase beta subunit (P4HB); and another protein to be hydroxylated. A method for providing skincare benefits including applying the fusion protein of the present disclosure on skin is also taught.Type: ApplicationFiled: August 16, 2019Publication date: October 7, 2021Inventors: Lixin DAI, Poonarn SRIVASTAVA
-
Patent number: 11028146Abstract: This invention relates to genetically engineered strains of yeast and methods for producing recombinant protein (e.g., collagen). Recombinant protein of the present invention is used to produce biofabricated leather or a material having leather-like properties containing recombinant or engineered collagen. The yeast strains are engineered to produce ascorbate and/or increased production of ? ketoglutarate.Type: GrantFiled: September 7, 2018Date of Patent: June 8, 2021Assignee: MODERN MEADOW, INC.Inventors: Lixin Dai, Kristin Ruebling-Jass, David Thomas Williamson
-
Patent number: 11001679Abstract: A biofabricated material containing a network of crosslinked collagen fibrils is disclosed. This material is composed of collagen which is also a major component of natural leather and is produced by a process of fibrillation of collagen molecules into fibrils, crosslinking the fibrils and lubricating the crosslinked fibrils. Unlike natural leathers, this biofabricated material exhibits non-anisotropic (not directionally dependent) physical properties, for example, a sheet of biofabricated material can have substantially the same elasticity or tensile strength when stretched or stressed in different directions. Unlike natural leather, it has a uniform texture that facilitates uniform uptake of dyes and coatings. Aesthetically, it produces a uniform and consistent grain for ease of manufacturability. It can have substantially identical grain, texture and other aesthetic properties on both sides distinct from natural leather where the grain increases from one side (e.g.Type: GrantFiled: March 19, 2019Date of Patent: May 11, 2021Assignee: Modern Meadow, Inc.Inventors: Brendan Patrick Purcell, David Thomas Williamson, Lixin Dai, Darryl Miles Cassingham, Stephen M. Spinella
-
Publication number: 20190203000Abstract: A biofabricated material containing a network of crosslinked collagen fibrils is disclosed. This material is composed of collagen which is also a major component of natural leather and is produced by a process of fibrillation of collagen molecules into fibrils, crosslinking the fibrils and lubricating the crosslinked fibrils. Unlike natural leathers, this biofabricated material exhibits non-anisotropic (not directionally dependent) physical properties, for example, a sheet of biofabricated material can have substantially the same elasticity or tensile strength when stretched or stressed in different directions. Unlike natural leather, it has a uniform texture that facilitates uniform uptake of dyes and coatings. Aesthetically, it produces a uniform and consistent grain for ease of manufacturability. It can have substantially identical grain, texture and other aesthetic properties on both sides distinct from natural leather where the grain increases from one side (e.g.Type: ApplicationFiled: March 19, 2019Publication date: July 4, 2019Applicant: MODERN MEADOW, INC.Inventors: Brendan Patrick PURCELL, David Thomas WILLIAMSON, Lixin DAI, Darryl Miles CASSINGHAM, Stephen M. SPINELLA
-
Patent number: 10301440Abstract: A biofabricated material containing a network of crosslinked collagen fibrils is disclosed. This material is composed of collagen which is also a major component of natural leather and is produced by a process of fibrillation of collagen molecules into fibrils, crosslinking the fibrils and lubricating the crosslinked fibrils. Unlike natural leathers, this biofabricated material exhibits non-anisotropic (not directionally dependent) physical properties, for example, a sheet of biofabricated material can have substantially the same elasticity or tensile strength when stretched or stressed in different directions. Unlike natural leather, it has a uniform texture that facilitates uniform uptake of dyes and coatings. Aesthetically, it produces a uniform and consistent grain for ease of manufacturability. It can have substantially identical grain, texture and other aesthetic properties on both sides distinct from natural leather where the grain increases from one side (e.g.Type: GrantFiled: February 15, 2017Date of Patent: May 28, 2019Assignee: MODERN MEADOW, INC.Inventors: Brendan Patrick Purcell, David Thomas Williamson, Lixin Dai, Darryl Miles Cassingham, Stephen M. Spinella
-
Publication number: 20190144957Abstract: The invention herein provides biofabricated materials having zonal properties and methods of making biofabricated materials having zonal properties.Type: ApplicationFiled: November 13, 2018Publication date: May 16, 2019Applicant: MODERN MEADOW, INC.Inventors: Brendan Patrick PURCELL, Suzanne LEE, Lixin DAI, Katherine Amy CONGDON, Stephen M. SPINELLA, Chi Man NG
-
Publication number: 20190092838Abstract: This invention relates to genetically engineered strains of yeast and methods for producing recombinant protein (e.g., collagen). Recombinant protein of the present invention is used to produce biofabricated leather or a material having leather-like properties containing recombinant or engineered collagen. The yeast strains are engineered to produce ascorbate and/or increased production of ? ketoglutarate.Type: ApplicationFiled: September 7, 2018Publication date: March 28, 2019Applicant: MODERN MEADOW, INC.Inventors: Lixin DAI, Poonam SRIVASTAVA
-
Publication number: 20190093116Abstract: This invention relates to genetically engineered strains of yeast and methods, for producing recombinant protein (e.g., collagen). Recombinant protein of the present invention is used to produce biofabricated leather or a material having leather-like properties containing recombinant or engineered collagen. The yeast strains are engineered to produce ascorbate and/or increased production of ? ketoglutarate.Type: ApplicationFiled: September 7, 2018Publication date: March 28, 2019Applicant: MODERN MEADOW, INC.Inventors: Lixin Dai, Kristin Ruebling-Jass, David Thomas Williamson
-
Publication number: 20190040400Abstract: Strains of yeast genetically engineered to produce increased amounts of non-hydroxylated collagen or hydroxylated collagen are described. A chimeric collagen DNA sequence, comprising from 10 to 40 percent or 60 to 90 percent of optimized DNA based on the total length of the chimeric collagen DN. An all-in-one vector including the DNA necessary to produce collagen, promotors, and hydroxylating enzymes is also described. Methods for producing non-hydroxylated or hydroxylated collagen are also provided.Type: ApplicationFiled: July 30, 2018Publication date: February 7, 2019Applicant: MODERN MEADOW, INC.Inventors: Lixin DAI, Julia BORDEN, Jeffrey NELSON, Kristin RUEBLING-JASS
-
Publication number: 20190002893Abstract: Strains of yeast genetically engineered to produce increased amounts of non-hydroxylated collagen or hydroxylated collagen are described. An all-in-one vector including the DNA necessary to produce collagen, promotors, and hydroxylating enzymes is also described. Methods for producing non-hydroxylated or hydroxylated collagen are also provided.Type: ApplicationFiled: June 29, 2018Publication date: January 3, 2019Applicant: MODERN MEADOW, INC.Inventors: Lixin Dai, Julia Borden, Jeffrey Nelson, Kristin Ruebling-Jass
-
Publication number: 20170233838Abstract: A biofabricated material containing a network of crosslinked collagen fibrils is disclosed. This material is composed of collagen which is also a major component of natural leather and is produced by a process of fibrillation of collagen molecules into fibrils, crosslinking the fibrils and lubricating the crosslinked fibrils. Unlike natural leathers, this biofabricated material exhibits non-anisotropic (not directionally dependent) physical properties, for example, a sheet of biofabricated material can have substantially the same elasticity or tensile strength when stretched or stressed in different directions. Unlike natural leather, it has a uniform texture that facilitates uniform uptake of dyes and coatings. Aesthetically, it produces a uniform and consistent grain for ease of manufacturability. It can have substantially identical grain, texture and other aesthetic properties on both sides distinct from natural leather where the grain increases from one side (e.g.Type: ApplicationFiled: February 15, 2017Publication date: August 17, 2017Applicant: MODERN MEADOW, INC.Inventors: Brendan Patrick PURCELL, David Thomas WILLIAMSON, Lixin DAI, Darryl Miles CASSINGHAM, Stephen M. SPINELLA